+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Neurovascular Thrombectomy Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 194 Pages
  • January 2024
  • Region: Global
  • Fairfield Market Research
  • ID: 5934342
The Neurovascular Thrombectomy Devices Market is set to experience significant growth over the next few years. The market is now expected to reach a market value of US$1500 million by 2031, up from US$800 million in 2024.

The surge in demand for Neurovascular Thrombectomy Devices can be attributed to several key factors:
  • Increase in Neurovascular Disorders: The rise in neurovascular disorders, coupled with the growing aging population, has significantly contributed to the demand for Neurovascular Thrombectomy Devices. These devices play a crucial role in the treatment and management of neurovascular illnesses.
  • Technological Advancements: The development of technologically sophisticated products has enhanced the efficacy and safety of Neurovascular Thrombectomy Devices, making them more attractive to healthcare providers and patients alike.
  • Awareness Initiatives: Efforts by various government and non-profit organizations to raise awareness about neurovascular diseases and their prevention have helped drive the market for these devices. Additionally, government subsidies and supportive reimbursement policies have further incentivized market growth.
  • Embolization Coils: The segment of embolic coils within the neurovascular devices market is expected to witness increased demand due to the rising occurrence of brain aneurysms and ischemic stroke. These coils are particularly beneficial for individuals at significant surgical risk, driving the need for less invasive procedures.

challenges:

  • Lack of Skilled Professionals: The market's growth potential is limited by the scarcity of skilled laboratory experts needed to operate advanced Neurovascular Thrombectomy devices. The demand for medical laboratory professionals is increasing, but the number of new graduates from clinical laboratory programs is decreasing.
  • High Equipment Costs: The high cost of Neurovascular Thrombectomy devices and the infrastructure required for diagnostic rooms, particularly in developing nations, pose a significant barrier to market expansion. This high cost also makes services inaccessible to many patients in low- and middle-income countries.

COVID-19 Impact

The COVID-19 pandemic had a moderate impact on the Neurovascular Thrombectomy Devices Market. Elective brain procedures were rescheduled during the pandemic to accommodate COVID-19 patients. Hospitals also postponed elective admissions and treatments, causing a decline in hospital admissions. Telemedicine became more prevalent during this time, impacting in-person treatment.

Competitive Analysis

The market is highly competitive and consolidated, with several large players. Key players in the Neurovascular Thrombectomy Devices Market are actively acquiring companies to expand their product offerings and increase their share of the global market.

Key Companies Profiled

  • Medtronic Plc
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
  • Johnson & Johnson Services, Inc.
  • Penumbra Inc.
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Acandis GmbH
  • Argon Medical Inc
  • Others.

Neurovascular Thrombectomy Devices Market Categorization

Neurovascular Thrombectomy Devices Market by Product

  • Stent Retriever
  • Aspiration Catheter

Neurovascular Thrombectomy Devices Market by Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa (MEA)


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Neurovascular Thrombectomy Devices Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Neurovascular Thrombectomy Devices Market Outlook, 2018 - 2031
3.1. Global Neurovascular Thrombectomy Devices Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Stent Retriever
3.1.1.2. Aspiration Catheter
3.2. Global Neurovascular Thrombectomy Devices Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Hospitals
3.2.1.2. Neuro-Catheterization Labs
3.2.1.3. Specialized Neurosurgery Centers
3.3. Global Neurovascular Thrombectomy Devices Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. North America
3.3.1.2. Europe
3.3.1.3. Asia Pacific
3.3.1.4. Latin America
3.3.1.5. Middle East & Africa
4. North America Neurovascular Thrombectomy Devices Market Outlook, 2018 - 2031
4.1. North America Neurovascular Thrombectomy Devices Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Stent Retriever
4.1.1.2. Aspiration Catheter
4.2. North America Neurovascular Thrombectomy Devices Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Hospitals
4.2.1.2. Neuro-Catheterization Labs
4.2.1.3. Specialized Neurosurgery Centers
4.2.2. BPS Analysis/Market Attractiveness Analysis
4.3. North America Neurovascular Thrombectomy Devices Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. U.S. Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
4.3.1.2. U.S. Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
4.3.1.3. Canada Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
4.3.1.4. Canada Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
4.3.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Neurovascular Thrombectomy Devices Market Outlook, 2018 - 2031
5.1. Europe Neurovascular Thrombectomy Devices Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Stent Retriever
5.1.1.2. Aspiration Catheter
5.2. Europe Neurovascular Thrombectomy Devices Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Hospitals
5.2.1.2. Neuro-Catheterization Labs
5.2.1.3. Specialized Neurosurgery Centers
5.2.2. BPS Analysis/Market Attractiveness Analysis
5.3. Europe Neurovascular Thrombectomy Devices Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Germany Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
5.3.1.2. Germany Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
5.3.1.3. U.K. Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
5.3.1.4. U.K. Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
5.3.1.5. France Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
5.3.1.6. France Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
5.3.1.7. Italy Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
5.3.1.8. Italy Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
5.3.1.9. Turkey Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
5.3.1.10. Turkey Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
5.3.1.11. Russia Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
5.3.1.12. Russia Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
5.3.1.13. Rest of Europe Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
5.3.1.14. Rest of Europe Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
5.3.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Neurovascular Thrombectomy Devices Market Outlook, 2018 - 2031
6.1. Asia Pacific Neurovascular Thrombectomy Devices Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Stent Retriever
6.1.1.2. Aspiration Catheter
6.2. Asia Pacific Neurovascular Thrombectomy Devices Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Hospitals
6.2.1.2. Neuro-Catheterization Labs
6.2.1.3. Specialized Neurosurgery Centers
6.2.2. BPS Analysis/Market Attractiveness Analysis
6.3. Asia Pacific Neurovascular Thrombectomy Devices Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. China Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
6.3.1.2. China Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
6.3.1.3. Japan Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
6.3.1.4. Japan Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
6.3.1.5. South Korea Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
6.3.1.6. South Korea Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
6.3.1.7. India Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
6.3.1.8. India Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
6.3.1.9. Southeast Asia Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
6.3.1.10. Southeast Asia Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
6.3.1.11. Rest of Asia Pacific Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
6.3.1.12. Rest of Asia Pacific Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
6.3.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Neurovascular Thrombectomy Devices Market Outlook, 2018 - 2031
7.1. Latin America Neurovascular Thrombectomy Devices Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Stent Retriever
7.1.1.2. Aspiration Catheter
7.2. Latin America Neurovascular Thrombectomy Devices Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
7.2.1. Key Highlights
7.2.1.1. Hospitals
7.2.1.2. Neuro-Catheterization Labs
7.2.1.3. Specialized Neurosurgery Centers
7.2.2. BPS Analysis/Market Attractiveness Analysis
7.3. Latin America Neurovascular Thrombectomy Devices Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Brazil Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
7.3.1.2. Brazil Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
7.3.1.3. Mexico Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
7.3.1.4. Mexico Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
7.3.1.5. Argentina Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
7.3.1.6. Argentina Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
7.3.1.7. Rest of Latin America Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
7.3.1.8. Rest of Latin America Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
7.3.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Neurovascular Thrombectomy Devices Market Outlook, 2018 - 2031
8.1. Middle East & Africa Neurovascular Thrombectomy Devices Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Stent Retriever
8.1.1.2. Aspiration Catheter
8.2. Middle East & Africa Neurovascular Thrombectomy Devices Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Hospitals
8.2.1.2. Neuro-Catheterization Labs
8.2.1.3. Specialized Neurosurgery Centers
8.2.2. BPS Analysis/Market Attractiveness Analysis
8.3. Middle East & Africa Neurovascular Thrombectomy Devices Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. GCC Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
8.3.1.2. GCC Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
8.3.1.3. South Africa Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
8.3.1.4. South Africa Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
8.3.1.5. Egypt Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
8.3.1.6. Egypt Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
8.3.1.7. Nigeria Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
8.3.1.8. Nigeria Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
8.3.1.9. Rest of Middle East & Africa Neurovascular Thrombectomy Devices Market by Product, Value (US$ Mn), 2018 - 2031
8.3.1.10. Rest of Middle East & Africa Neurovascular Thrombectomy Devices Market by End User, Value (US$ Mn), 2018 - 2031
8.3.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. By Product vs by End User Heatmap
9.2. Company Market Share Analysis, 2023
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Medtronic Plc
9.4.1.1. Company Overview
9.4.1.2. Therapy Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Development
9.4.2. Stryker Corporation
9.4.2.1. Company Overview
9.4.2.2. Therapy Portfolio
9.4.2.3. Financial Overview
9.4.2.4. Business Strategies and Development
9.4.3. Teleflex Incorporated
9.4.3.1. Company Overview
9.4.3.2. Therapy Portfolio
9.4.3.3. Financial Overview
9.4.3.4. Business Strategies and Development
9.4.4. Terumo Corporation
9.4.4.1. Company Overview
9.4.4.2. Therapy Portfolio
9.4.4.3. Financial Overview
9.4.4.4. Business Strategies and Development
9.4.5. Johnson & Johnson Services, Inc.
9.4.5.1. Company Overview
9.4.5.2. Therapy Portfolio
9.4.5.3. Financial Overview
9.4.5.4. Business Strategies and Development
9.4.6. Penumbra Inc.
9.4.6.1. Company Overview
9.4.6.2. Therapy Portfolio
9.4.6.3. Financial Overview
9.4.6.4. Business Strategies and Development
9.4.7. Boston Scientific Corporation
9.4.7.1. Company Overview
9.4.7.2. Therapy Portfolio
9.4.7.3. Financial Overview
9.4.7.4. Business Strategies and Development
9.4.8. Edwards Lifesciences Corporation
9.4.8.1. Company Overview
9.4.8.2. Therapy Portfolio
9.4.8.3. Financial Overview
9.4.8.4. Business Strategies and Development
9.4.9. Acandis GmbH
9.4.9.1. Company Overview
9.4.9.2. Therapy Portfolio
9.4.9.3. Financial Overview
9.4.9.4. Business Strategies and Development
9.4.10. Argon Medical Inc
9.4.10.1. Company Overview
9.4.10.2. Therapy Portfolio
9.4.10.3. Financial Overview
9.4.10.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Medtronic Plc
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
  • Johnson & Johnson Services, Inc.
  • Penumbra Inc.
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Acandis GmbH
  • Argon Medical Inc

Methodology

Loading
LOADING...